Sample collection for AIS progression is quick, and will take place right in your doctor's office at Schumacher Chiropractic Clinic. Your child will be asked to provide a saliva sample, which will then be sent for analysis at a lab located at Axial Biotech headquarters. From your child’s saliva, the lab will analyze their DNA for indicators associated with the likelihood for scoliosis progression. The ScoliScore™ Test has the ability to distinguish between patients who are likely to progress to a severe curve, and those who might not. The test performed on your child’s saliva is strictly confidential, and only your child’s doctor will receive the results.
The ScoliScore™ test uses specific DNA markers to predict the likelihood that an AIS curve will progress.
Researchers identified 28 signs in DNA that an AIS curve will progress (progressive genes), and 25 signs in DNA that an AIS curve will not progress (protective genes).
The ability of The ScoliScore™ Test to predict whether a curve will progress has been demonstrated in clinical studies involving multiple samples of children with AIS.
The ScoliScore™ Test can only be ordered by an authorized healthcare professional, such as your doctor at Schumacher Chiropractic Clinics, P.A.
The ScoliScore™ Test is appropriate for (Indications):The ScoliScore™ Test is performed by collecting a saliva sample during a visit to your doctors office at Schumacher Chiropractic Clinic. Your child will not need to have blood drawn.
It will typically take 2-3 weeks from the date the sample is received by Axial Biotech Laboratories for the results to be available. The ScoliScore™ Test report form is sent directly to the doctor treating your child.
The ScoliScore™ Test should be administered by Schumacher Chiropractic Clinics, P.A. prior to beginning scoliosis treatment, since the ScoliScore™ Test may help doctors make more informed decisions about how to manage your child's curve.
The ScoliScore™ Test provides your child's doctor with a score from 1-200. This score accurately corresponds to the low, intermediate, or high likelihood of your child's curve progressing to one greater than 40°.
The results of the ScoliScore™ Test can help your doctor understand how likely your child's curve is to progress or not, but the test will not specifically identify which treatments to use. The results of the ScoliScore™ Test should be used with other diagnostic information to help you and your doctor determine which treatment option is best for your child.
The ScoliScore™ Test costs $2,950 and is likely to be covered by insurance because the test utilizes well established Diagnostic CPT codes. Patients should check with their insurance providers to determine individual coverage. The Axial Biotech Reimbursement Team is also available to help verify whether someone's healthcare insurance covers the test and to make the insurance billing process as easy as possible for doctors.
Axial Biotech believes that every eligible patient should have access to the ScoliScore™ Test. The company offers the following programs:
For more information, please contact Schumacher Chiropractic Clinic at 952-931-9867 (Hopkins Clinic) or 651-776-8666 (St Paul Clinic).
Do you have questions about scoliosis screening or administering the ScoliScore™ AIS Prognostic Test? Please call us, we will be happy to assist you.
Schumacher Chiropractic Clinics, P.A.
|
|
|
Home | Services | Products | Hopkins | St Paul | Patients | ScoliScore | Spine | Contact Hopkins | Contact St Paul | Disclaimer & Privacy | Videos | Help | Sitemap |
View Site in Mobile

The SCOLISCORE AIS Prognostic Test was designed and validated by Axial Biotech, Inc. and is co-marketed and sold by both DePuy Spine, Inc. and Smith & Nephew, Inc.
Indications for Use: The SCOLISCORE™ AIS Prognostic Test is intended for in vitro use only. The SCOLISCORE Test is indicated for Caucasian, adolescent males and females between the ages of 9-13 years with a mild curve (Cobb angle 10-25°). This test utilizes DNA extracted from a saliva specimen in a polymerase chain reaction to detect the genotypes for genetic markers found in clinical trials to be associated with severe curve progression in patients diagnosed with Adolescent Idiopathic Scoliosis (AIS). Results from the SCOLISCORE Test are intended for use as an adjunct to existing clinical and radiologic information to determine the risk of curve progression. For additional information regarding indications for use, please see the SCOLISCORE Test package insert.
Caution: The SCOLISCORE™ Test is designed to accurately predict the likelihood of severe curve progression for patients diagnosed with Mild AIS and who received a SCOLISCORE in the Low Risk Classification (1- 50). Therefore, care should be exercised when utilizing the risk of progression for patients in the Intermediate Risk (51 � 179) and High Risk Classifications (180 � 200). The SCOLISCORE Test information should always be interpreted with all other clinical factors when determining the appropriate clinical treatment and care of patients. Under Federal law, this test may only be performed on the order of a physician and its results may only be reported to the ordering physician.